Scientists Solve the Crystal Structure of the Fumarate Salts of DMT and Psilocin Derivatives
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
Anorexia has phenomenological parallels to anxiety and addiction, both of which have been shown to improve with psilocybin-assisted interventions.
Psilacetin is less expensive and easier to make than psilocybin.
The answer is yes and no. It's a matter of perspective.
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.